TESTBANK k
Tietz Fundamentals Of
kk kk
CLINICAL CHEMISTRY AND
kk kk
MOLECULAR
kk
DIAGNOSTICS
k k
7th Edition By Carl A. Burtis
kk kk kk kk kk
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
kk kk kk kk kk kk kk kk
kk
kk kk
Table of contents:
kk kk
I. Principles Of Laboratory Medicine
kk kk kk kk
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
kk kk kk kk kk kk kk kk
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
kk kk kk kk kk kk kk kk kk kk kk
Chapter 3. Clinical Evaluation of Methods
kk kk kk kk kk
Chapter 4. Evidence-Based Laboratory Medicine
kk kk kk kk
Chapter 5. Establishment and Use of Reference Values
kk kk kk kk kk kk kk
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
kk kk kk kk kk kk kk kk
Chapter 7. Quality Management
kk kk kk
II. Analytical Techniques And Instrumentation
kk kk kk kk
Chapter 8. Principles of Basic Techniques and Laboratory Safety
kk kk kk kk kk kk kk kk
Chapter 9. Optical Techniques
kk kk kk
Chapter 10. Electrochemistry and Chemical Sensors
kk kk kk kk kk
Chapter 11. Electrophoresis
kk kk
Chapter 12. Chromatography
kk kk
Chapter 13. Mass Spectrometry
kk kk kk
Chapter 14. Enzyme and Rate Analyses
kk kk kk kk kk
Chapter 15. Immunochemical Techniques
kk kk kk
Chapter 16 Automation kk kk
Chapter 17. Point-of-Care Instrumentation
kk kk kk
III. Analytes
k k
Chapter 18. Amino Acids, Peptides, and Proteins
kk kk kk kk kk kk
Chapter 19. Serum Enzymes
kk kk kk
Chapter 20. Tumor Markers and Cancer Genes
kk kk kk kk kk kk
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
kk kk kk kk kk kk kk kk kk kk kk
Chapter 22. Carbohydrates
kk kk
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
kk kk kk kk kk kk kk kk kk
Chapter 24. Electrolytes and Blood Gases
kk kk kk kk kk
Chapter 25. Hormones kk kk
Chapter 26. Catecholamines and Serotonin
kk k k kk kk
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
kk k k kk kk kk kk
Chapter 28. Hemoglobin, Iron, and Bilirubin
kk kk kk kk kk
Chapter 29. Porphyrins and Porphyrias
kk kk kk kk
Chapter 30. Therapeutic Drugs and Their Management
kk kk kk kk kk kk
Chapter 31. Clinical Toxicology
kk kk kk
Chapter 32. Toxic Metals
kk k k kk
IV. Pathophysiology
k k
Chapter 33. Diabetes kk kk
,Chapter 34. Cardiovascular Disease
kk k k kk
Chapter 35. Kidney Disease
kk k k kk
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
kk k k kk kk kk kk kk kk kk kk
Chapter 37. Liver Disease
kk k k kk
Chapter 38. Gastrointestinal and Pancreatic Diseases
kk k k kk kk kk
Chapter 39. Disorders of Bone and Mineral Metabolism
kk k k kk kk kk kk kk
Chapter 40. Disorders of the Pituitary Gland
kk k k kk kk kk kk
Chapter 41. Disorders of the Adrenal Cortex
kk k k kk kk kk kk
Chapter 42. Thyroid Disorders
kk k k kk
Chapter 43. Reproduction-Related Disorders
kk k k kk
Chapter 44. Pregnancy and Prenatal Testing
kk k k kk kk kk
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
kk k k kk kk kk kk kk kk
Chapter 46. Pharmacogenetics
kk kk
V. Molecular Diagnostics
k k kk
Chapter 47. Principles of Molecular Biology
kk kk kk kk kk
Chapter 48. Nucleic Acid Techniques and Applications
kk kk kk kk kk kk
Chapter 49. Genomes and Nucleic Acid Alterations
kk kk kk kk kk kk
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
kk kk kk kk kk kk kk kk kk kk
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest
kk kk kk kk kk kk kk kk
Bank
kk
MULTIPLE CHOICE kk
1. An individual working in a clinical chemistry laboratory is married to a sales
kk kk kk kk kk kk kk kk kk kk kk kk
representative who works for a company that sells chemistry laboratory supplies.
kk kk kk kk kk kk kk kk kk kk kk
When the laboratory manager requests a list of needed supplies, cost of supplies, and
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
vendors, this individual only recommends the spouse’s company as the vendor. This is
kk kk kk kk kk kk kk kk kk kk kk kk kk
considered to be a(n):
kk kk kk kk
a. accounting issue. kk
b. possible conflict of interest. kk kk kk
c. maintenance of confidentiality issue. kk kk kk
d. problem with resource allocation. kk kk kk
ANS: B kk
Concern has been raised over the interrelationships between practitioners in the medical
kk kk kk kk kk kk kk kk kk kk kk
field and commercial suppliers of drugs, devices, equipment, etc., to the medical
kk kk kk kk kk kk kk kk kk kk kk kk
profession.
kk
Similarly, relationships have been scrutinized between clinical laboratorians and
kk kk kk kk kk kk kk kk
manufacturers and providers of diagnostic equipment and supplies. These concerns led
kk kk kk kk kk kk kk kk kk kk kk
the National Institutes of Health (NIH) in 1995 to require official institutional review of
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
financial disclosure by researchers and management of situations in which disclosure
kk kk kk kk kk kk kk kk kk kk kk
indicates potential conflicts of interest.
kk kk kk kk kk
DIF: 1 REF: kk kk Page 4-5 kk OBJ: 6 | 7 kk kk kk
2. A patient visits her physician stating that her prescribed painkiller is not working to
kk kk kk kk kk kk kk kk kk kk kk kk kk
reduce the pain following her recent surgery. A friend of the patient claims that the
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
same painkiller ―worked wonders‖ to reduce her pain after the same surgery. The
kk kk kk kk kk kk kk kk kk kk kk kk kk
physician states that the difference in the effect of the drug might be caused by ,
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
which is studied in pharmacogenetics.
kk kk kk kk kk
a. epidemiology
b. an inherited disease kk kk
c. a conflict of interest
kk kk kk
d. a genetic variation in drug-metabolizing enzymes
kk kk kk kk kk
ANS: D kk
Pharmacogenetics is the study of the genetic variation of drug metabolism between kk kk kk kk kk kk kk kk kk kk kk
individuals.
kk
DIF: 1 REF: kk kk Page 3 kk OBJ: 1 kk
3. John works in a molecular diagnostics laboratory and receives a blood sample that
kk kk kk kk kk kk kk kk kk kk kk kk
has the name of a close friend printed on the bar-coded label. The genetic test that is
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
ordered on the friend’s sample would provide diagnostic information about a disorder
kk kk kk kk kk kk kk kk kk kk kk kk
that has a poor prognosis, and the test is usually performed by John. He asks a
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
fellow employee to analyze the sample for him and not divulge the results. This
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
ethical issue concerns:
kk kk kk
a. confidentiality of patient genetic and medical information. kk kk kk kk kk kk
b. a conflict of interest.
kk kk kk
c. resource allocation. kk
d. diagnostic accuracy. kk
Tietz Fundamentals Of
kk kk
CLINICAL CHEMISTRY AND
kk kk
MOLECULAR
kk
DIAGNOSTICS
k k
7th Edition By Carl A. Burtis
kk kk kk kk kk
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
kk kk kk kk kk kk kk kk
kk
kk kk
Table of contents:
kk kk
I. Principles Of Laboratory Medicine
kk kk kk kk
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
kk kk kk kk kk kk kk kk
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
kk kk kk kk kk kk kk kk kk kk kk
Chapter 3. Clinical Evaluation of Methods
kk kk kk kk kk
Chapter 4. Evidence-Based Laboratory Medicine
kk kk kk kk
Chapter 5. Establishment and Use of Reference Values
kk kk kk kk kk kk kk
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
kk kk kk kk kk kk kk kk
Chapter 7. Quality Management
kk kk kk
II. Analytical Techniques And Instrumentation
kk kk kk kk
Chapter 8. Principles of Basic Techniques and Laboratory Safety
kk kk kk kk kk kk kk kk
Chapter 9. Optical Techniques
kk kk kk
Chapter 10. Electrochemistry and Chemical Sensors
kk kk kk kk kk
Chapter 11. Electrophoresis
kk kk
Chapter 12. Chromatography
kk kk
Chapter 13. Mass Spectrometry
kk kk kk
Chapter 14. Enzyme and Rate Analyses
kk kk kk kk kk
Chapter 15. Immunochemical Techniques
kk kk kk
Chapter 16 Automation kk kk
Chapter 17. Point-of-Care Instrumentation
kk kk kk
III. Analytes
k k
Chapter 18. Amino Acids, Peptides, and Proteins
kk kk kk kk kk kk
Chapter 19. Serum Enzymes
kk kk kk
Chapter 20. Tumor Markers and Cancer Genes
kk kk kk kk kk kk
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
kk kk kk kk kk kk kk kk kk kk kk
Chapter 22. Carbohydrates
kk kk
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
kk kk kk kk kk kk kk kk kk
Chapter 24. Electrolytes and Blood Gases
kk kk kk kk kk
Chapter 25. Hormones kk kk
Chapter 26. Catecholamines and Serotonin
kk k k kk kk
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
kk k k kk kk kk kk
Chapter 28. Hemoglobin, Iron, and Bilirubin
kk kk kk kk kk
Chapter 29. Porphyrins and Porphyrias
kk kk kk kk
Chapter 30. Therapeutic Drugs and Their Management
kk kk kk kk kk kk
Chapter 31. Clinical Toxicology
kk kk kk
Chapter 32. Toxic Metals
kk k k kk
IV. Pathophysiology
k k
Chapter 33. Diabetes kk kk
,Chapter 34. Cardiovascular Disease
kk k k kk
Chapter 35. Kidney Disease
kk k k kk
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
kk k k kk kk kk kk kk kk kk kk
Chapter 37. Liver Disease
kk k k kk
Chapter 38. Gastrointestinal and Pancreatic Diseases
kk k k kk kk kk
Chapter 39. Disorders of Bone and Mineral Metabolism
kk k k kk kk kk kk kk
Chapter 40. Disorders of the Pituitary Gland
kk k k kk kk kk kk
Chapter 41. Disorders of the Adrenal Cortex
kk k k kk kk kk kk
Chapter 42. Thyroid Disorders
kk k k kk
Chapter 43. Reproduction-Related Disorders
kk k k kk
Chapter 44. Pregnancy and Prenatal Testing
kk k k kk kk kk
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
kk k k kk kk kk kk kk kk
Chapter 46. Pharmacogenetics
kk kk
V. Molecular Diagnostics
k k kk
Chapter 47. Principles of Molecular Biology
kk kk kk kk kk
Chapter 48. Nucleic Acid Techniques and Applications
kk kk kk kk kk kk
Chapter 49. Genomes and Nucleic Acid Alterations
kk kk kk kk kk kk
, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
kk kk kk kk kk kk kk kk kk kk
Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest
kk kk kk kk kk kk kk kk
Bank
kk
MULTIPLE CHOICE kk
1. An individual working in a clinical chemistry laboratory is married to a sales
kk kk kk kk kk kk kk kk kk kk kk kk
representative who works for a company that sells chemistry laboratory supplies.
kk kk kk kk kk kk kk kk kk kk kk
When the laboratory manager requests a list of needed supplies, cost of supplies, and
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
vendors, this individual only recommends the spouse’s company as the vendor. This is
kk kk kk kk kk kk kk kk kk kk kk kk kk
considered to be a(n):
kk kk kk kk
a. accounting issue. kk
b. possible conflict of interest. kk kk kk
c. maintenance of confidentiality issue. kk kk kk
d. problem with resource allocation. kk kk kk
ANS: B kk
Concern has been raised over the interrelationships between practitioners in the medical
kk kk kk kk kk kk kk kk kk kk kk
field and commercial suppliers of drugs, devices, equipment, etc., to the medical
kk kk kk kk kk kk kk kk kk kk kk kk
profession.
kk
Similarly, relationships have been scrutinized between clinical laboratorians and
kk kk kk kk kk kk kk kk
manufacturers and providers of diagnostic equipment and supplies. These concerns led
kk kk kk kk kk kk kk kk kk kk kk
the National Institutes of Health (NIH) in 1995 to require official institutional review of
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
financial disclosure by researchers and management of situations in which disclosure
kk kk kk kk kk kk kk kk kk kk kk
indicates potential conflicts of interest.
kk kk kk kk kk
DIF: 1 REF: kk kk Page 4-5 kk OBJ: 6 | 7 kk kk kk
2. A patient visits her physician stating that her prescribed painkiller is not working to
kk kk kk kk kk kk kk kk kk kk kk kk kk
reduce the pain following her recent surgery. A friend of the patient claims that the
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
same painkiller ―worked wonders‖ to reduce her pain after the same surgery. The
kk kk kk kk kk kk kk kk kk kk kk kk kk
physician states that the difference in the effect of the drug might be caused by ,
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
which is studied in pharmacogenetics.
kk kk kk kk kk
a. epidemiology
b. an inherited disease kk kk
c. a conflict of interest
kk kk kk
d. a genetic variation in drug-metabolizing enzymes
kk kk kk kk kk
ANS: D kk
Pharmacogenetics is the study of the genetic variation of drug metabolism between kk kk kk kk kk kk kk kk kk kk kk
individuals.
kk
DIF: 1 REF: kk kk Page 3 kk OBJ: 1 kk
3. John works in a molecular diagnostics laboratory and receives a blood sample that
kk kk kk kk kk kk kk kk kk kk kk kk
has the name of a close friend printed on the bar-coded label. The genetic test that is
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
ordered on the friend’s sample would provide diagnostic information about a disorder
kk kk kk kk kk kk kk kk kk kk kk kk
that has a poor prognosis, and the test is usually performed by John. He asks a
kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk kk
fellow employee to analyze the sample for him and not divulge the results. This
kk kk kk kk kk kk kk kk kk kk kk kk kk kk
ethical issue concerns:
kk kk kk
a. confidentiality of patient genetic and medical information. kk kk kk kk kk kk
b. a conflict of interest.
kk kk kk
c. resource allocation. kk
d. diagnostic accuracy. kk